Assay optimization for the objective quantification of human multilineage colony-forming units

Area of Science:

• Hematopoietic stem cell biology
• Cellular immunology
• Biotechnology

Background:

• Colony-forming unit (CFU) assays are crucial for evaluating hematopoietic stem and progenitor cell lineage potential.
• Current CFU assays face limitations in robustly assessing multipotent progenitors due to insufficient growth factors and subjective manual counting.
• Variability in manual colony assessment impacts the reliability of progenitor identification.

Purpose of the Study:

• To improve the accuracy, reproducibility, and throughput of myeloid CFU assays.
• To enable robust assessment of multipotent progenitors across myeloid, erythroid, and megakaryocytic lineages.
• To introduce an objective method for analyzing CFU assay results.

Main Methods:

• Supplementation of MegaCult medium with granulocyte colony-stimulating factor (G-CSF), macrophage (M)-CSF, and granulocyte-macrophage (GM)-CSF.
• Utilizing in situ immunofluorescence (IF) with lineage-specific antibodies (anti-CD66b, anti-CD14, anti-CD235a, anti-CD41) for objective cell detection.
• Analysis of IF-stained colonies via microscopy and high-throughput microscopy.

Main Results:

• Optimized culture conditions promote differentiation of common myeloid progenitors into expected proportions of granulocytic (G), monocytic (M), erythroid (E), and megakaryocytic (Mk) colonies.
• In situ immunofluorescence provides objective identification of G, M, E, and Mk cells within colonies.
• High-throughput microscopy enables efficient analysis of stained colonies.

Conclusions:

• Enhanced culture media and objective immunofluorescence detection significantly improve myeloid CFU assay performance.
• The refined assay increases accuracy, reproducibility, and throughput for hematopoietic progenitor analysis.
• This improved method validates progenitor populations identified by techniques like fluorescence-activated cell sorting (FACS).